AVEO PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$1.1M, a 4.77% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$4.55M, a 203% decline year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$3.79M, a 215% decline from 2020.
  • Aveo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was $3.29M, a 66.3% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2019 was $9.76M, a 51.3% decline from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$4.55M -$1.1M +$55K +4.77% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$4.6M -$1.17M -$2.63M -179% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$1.97M -$1.19M +$1.82M +60.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$3.79M -$1.1M -$2.29M -192% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 -$1.5M -$1.15M -$820K -246% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$681K $1.47M +$1.37M +1352% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$2.05M -$3.01M -$5.34M -229% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $3.29M $1.19M -$981K -45.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $4.27M -$333K +$2.09M +86.2% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 $2.19M $101K -$1.66M -94.3% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 $3.84M $2.33M -$5.92M -71.7% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 $9.76M $2.17M +$443K +25.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $9.32M -$2.42M +$14.3M +85.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$5.01M $1.76M -$8.82M -83.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3.81M $8.25M +$10.2M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 -$6.4M $1.73M +$2.37M Oct 1, 2018 Dec 31, 2018 10-K 2019-03-14
Q3 2018 -$8.77M -$16.8M -$16.1M -2457% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $7.33M $10.6M +$11.1M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$3.78M -$1.96M -$1.41M -255% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$2.37M -$637K +$111K +14.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$2.48M -$655K -$104K -18.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 -$2.38M -$530K -$62K -13.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$2.32M -$551K -$174K -46.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 -$2.14M -$748K -$286K -61.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$1.86M -$551K +$2K +0.36% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$1.86M -$468K +$367K +44% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 -$2.23M -$377K +$348K +48% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 -$2.58M -$462K +$439K +48.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$3.01M -$553K -$216K -64.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-22
Q2 2015 -$2.8M -$835K -$341K -69% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-22
Q1 2015 -$2.46M -$725K -$167K -29.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-22
Q4 2014 -$2.29M -$901K -$245K -37.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$2.05M -$337K +$361K +51.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$2.41M -$494K +$347K +41.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$2.75M -$558K +$372K +40% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$3.13M -$656K +$226K +25.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-06
Q3 2013 -$3.35M -$698K +$43K +5.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-06
Q2 2013 -$3.39M -$841K -$54K -6.86% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-06
Q1 2013 -$3.34M -$930K -$583K -168% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-06
Q4 2012 -$2.76M -$882K -$145K -19.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 -$2.61M -$741K -$18K -2.49% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-13
Q2 2012 -$2.59M -$787K +$49K +5.86% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-13
Q1 2012 -$2.64M -$347K +$656K +65.4% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-13
Q4 2011 -$3.3M -$737K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 -$723K +$244K +25.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$836K +$443K +34.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 -$1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$967K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$1.28M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.